All Stories

  1. A rapid CRISPR-based nanodroplet assay enables direct clinical identification of mycobacteria species
  2. Direct delivery of assay reagents to extracellular vesicles in liquid biopsies for biomarker analysis
  3. Hippocampal Bioenergetics and Metabolic Profiling Identifies Fatty Acid Oxidation as a Potential Therapeutic Target in Traumatic Brain Injury
  4. Sensitive pathogen DNA detection by a multi-guide RNA Cas12a assay favoring trans- versus cis-cleavage
  5. Self-powered rapid antigen-specific T-cell response assay for Mycobacterium tuberculosis infections
  6. Rapid tuberculosis diagnosis from respiratory or blood samples by a low cost, portable lab-in-tube assay
  7. Precise mycobacterial species and subspecies identification using the PEP-TORCH peptidome algorithm
  8. CRISPR-mediated detection of Pneumocystis transcripts in bronchoalveolar, oropharyngeal, and serum specimens for Pneumocystis pneumonia diagnosis
  9. Applications of Nanotechnology for Spatial Omics: Biological Structures and Functions at Nanoscale Resolution
  10. Post‐COVID immunity in patients with solid tumor or hematological malignancies treated with SARS‐CoV‐2 monoclonal antibodies
  11. Serum Cell-Free DNA-based Detection of Mycobacterium avium Complex Infection
  12. Improving Targeted Mass Spectrometry Data Analysis with Nested Active Machine Learning
  13. Mapping dynamic molecular changes in hippocampal subregions after traumatic brain injury through spatial proteomics
  14. Altered COVID-19 immunity in children with asthma by atopic status
  15. Development of a CRISPR-Cas12a rapid diagnostic for human cytomegalovirus
  16. Chromatin-Accessible miRNA Regulons Driving Thyroid Tumorigenesis and Progression
  17. Evaluation of SARS-CoV-2-Specific T-Cell Activation with a Rapid On-Chip IGRA
  18. Extracellular vesicles: Emerging tools as therapeutic agent carriers
  19. A miRNA-Based Prognostic Model to Trace Thyroid Cancer Recurrence
  20. Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples
  21. Understanding Immune‐Driven Brain Aging by Human Brain Organoid Microphysiological Analysis Platform
  22. CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study
  23. Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and Age
  24. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates
  25. CRISPR-based assay reveals SARS-CoV-2 RNA dynamic changes and redistribution patterns in non-human primate model
  26. Rapid detection of multiple SARS-CoV-2 variants of concern by PAM-targeting mutations
  27. Liposome-mediated detection of SARS-CoV-2 RNA-positive extracellular vesicles in plasma
  28. High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies
  29. Evaluation of a serum-based antigen test for tuberculosis in HIV-exposed infants: a diagnostic accuracy study
  30. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection
  31. A smartphone-read ultrasensitive and quantitative saliva test for COVID-19
  32. Correction: The PorX/PorY system is a virulence factor of Porphyromonas gingivalis and mediates the activation of the type IX secretion system
  33. The PorX/PorY system is a virulence factor of Porphyromonas gingivalis and mediates the activation of the type IX secretion system
  34. Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patients
  35. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis
  36. Circulating levels of hydroxylated bradykinin function as an indicator of tissue HIF-1α expression
  37. Beclin 2 negatively regulates innate immune signaling and tumor development
  38. Neuropathology and Virus in Brain of SARS-CoV-2 Infected Non-Human Primates
  39. COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
  40. Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non–small cell lung cancer after concurrent chemoradiation
  41. Cathepsin B Dependent Cleavage Product of Serum Amyloid A1 Identifies Patients with Chemotherapy-Related Cardiotoxicity
  42. Tumor‐derived exosomes (TDEs): How to avoid the sting in the tail
  43. Rapid Lipid-Based Approach for Normalization of Quantum-Dot-Detected Biomarker Expression on Extracellular Vesicles in Complex Biological Samples
  44. Nanotrap-enabled quantification of KRAS-induced peptide hydroxylation in blood for cancer early detection
  45. Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application
  46. Enhanced Natural Killer Cell Immunotherapy by Rationally Assembling Fc Fragments of Antibodies onto Tumor Membranes
  47. PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4
  48. Tgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer
  49. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer
  50. USP26 functions as a negative regulator of cellular reprogramming by stabilising PRC1 complex components
  51. Circulating Peptidome and Tumor-Resident Proteolysis
  52. Drug Discovery via Human-Derived Stem Cell Organoids
  53. Targeting epigenetic regulations in cancer
  54. 5-Aza-2′-deoxycytidine Activates Iron Uptake and Heme Biosynthesis by Increasing c-Myc Nuclear Localization and Binding to the E-boxes of Transferrin Receptor 1 (TfR1) and Ferrochelatase (Fech) Genes
  55. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses
  56. Direct evidence for catalase and peroxidase activities of ferritin–platinum nanoparticles
  57. Lysosomal Proteolysis Is the Primary Degradation Pathway for Cytosolic Ferritin and Cytosolic Ferritin Degradation Is Necessary for Iron Exit
  58. Neuroprotective Mechanism of Mitochondrial Ferritin on 6-Hydroxydopamine–Induced Dopaminergic Cell Damage: Implication for Neuroprotection in Parkinson's Disease